Literature DB >> 20117098

Structure and function of the apoA-IV T347S and Q360H common variants.

Monica Gomaraschi1, Wendy E Putt, Silvia Pozzi, Stefania Iametti, Alberto Barbiroli, Francesco Bonomi, Elda Favari, Franco Bernini, Guido Franceschini, Philippa J Talmud, Laura Calabresi.   

Abstract

Human apolipoprotein A-IV (apoA-IV) is involved in chylomicron assembly and secretion, and in reverse cholesterol transport. Several apoA-IV isoforms exist, the most common in Caucasian populations being apoA-IV-1a (T347S) and apoA-IV-2 (Q360H). The objective of the present study was to investigate the impact of these common aminoacid substitutions on the ability of apoA-IV to bind lipids, to promote cell cholesterol efflux via ABCA1, and to maintain endothelial homeostasis. Recombinant forms of wild-type apoA-IV, apoA-IV Q360H, and apoA-IV T347S were produced in Escherichia coli. ApoA-IV Q360H and apoA-IV T347S showed a slightly higher alpha-helical content compared to wild-type apoA-IV, and associated with phospholipids faster than wild-type apoA-IV. The capacity to promote ABCA1-mediated cholesterol efflux was significantly greater for the apoA-IV T347S than the other apoA-IV isoforms. No differences were observed in the ability of apoA-IV isoforms to inhibit the production of VCAM-1 and IL-6 in TNFalpha-stimulated endothelial cells. In conclusion, the apoA-IV T347S common variant has increased lipid binding properties and cholesterol efflux capacity, while the apoA-IV Q360H variant has only slightly increased lipid binding properties. The two common aminoacid substitutions have no effect on the ability of apoA-IV to maintain endothelial homeostasis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117098     DOI: 10.1016/j.bbrc.2010.01.099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Dietary oil modifies the plasma proteome during aging in the rat.

Authors:  Mónica Santos-González; José López-Miranda; Francisco Pérez-Jiménez; Plácido Navas; José M Villalba
Journal:  Age (Dordr)       Date:  2011-04-07

Review 2.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

3.  ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.

Authors:  Adelina Duka; Panagiotis Fotakis; Dimitra Georgiadou; Andreas Kateifides; Kalliopi Tzavlaki; Leonard von Eckardstein; Efstratios Stratikos; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2012-11-06       Impact factor: 5.922

4.  Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity.

Authors:  Katya B Rubinow; Tomas Vaisar; Chongren Tang; Alvin M Matsumoto; Jay W Heinecke; Stephanie T Page
Journal:  J Lipid Res       Date:  2012-04-13       Impact factor: 5.922

5.  Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity.

Authors:  Jeong-Ah Yoo; Eun-Young Lee; Ji Yoon Park; Seung-Taek Lee; Sihyun Ham; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

6.  A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.

Authors:  Claudia Lamina; Salome Friedel; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Barbara Kollerits; Pedro Marques-Vidal; Janina Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Stefan Kiechl; Olli T Raitakari; Mika Kähönen; Johann Willeit; Ludmilla Kedenko; Bernhard Paulweber; Annette Peters; Thomas Meitinger; Konstantin Strauch; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Florian Kronenberg
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

7.  Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages.

Authors:  Ligia Shimabukuro Okuda; Rodrigo Tallada Iborra; Paula Ramos Pinto; Ubiratan Fabres Machado; Maria Lucia Corrêa-Giannella; Russell Pickford; Tom Woods; Margaret Anne Brimble; Kerry-Anne Rye; Marisa Passarelli
Journal:  Mediators Inflamm       Date:  2020-01-14       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.